Related Experiment Video
Updated: May 5, 2026

Real-Time Void Spot Assay
Published on: February 10, 2023
Functional consequences of chronic bladder ischemia
Osamu Yamaguchi1, Masanori Nomiya, Karl-Erik Andersson
1Division of Bioengineering and LUTD Research, Nihon University College of Engineering, Koriyama, Japan.
Abstract:
The pathophysiology of lower urinary tract symptoms (LUTS), particularly in the elderly, seems to be multifactorial. One of the factors involved may be chronic ischemia of the bladder caused by bladder outflow obstruction (male) or atherosclerosis (male/female). The mechanisms by which chronic ischemia initiates and causes LUTS and progressive bladder dysfunction, and the time course of the effects, are incompletely known. Bladder ischemia and repeated ischemia/reperfusion during a micturition cycle may produce oxidative stress, leading to denervation of the bladder and the expression of tissue damaging molecules in the bladder wall. This may be responsible for the development of detrusor overactivity progressing to detrusor underactivity and inability to empty the bladder. The extent of bladder dysfunction in chronic bladder ischemia may depend on the degree and duration of ischemia. To prevent chronic bladder ischemia caused by atherosclerosis and to treat its consequences, more pathophysiological knowledge is needed. Several animal models of atherosclerosis-induced chronic bladder ischemia are available and should be useful tools for further research.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Chronic Kidney Disease II: Clinical Manifestations
Urinary Tract Infection II: Pathophysiology
Disorders of the Urinary System
Urinary tract infections (UTIs) are one of the most common urinary system disorders. They are caused by bacteria that enter the urethra and can spread to the bladder resulting in cystitis. Pyelonephritis is the result of a UTI that has ascended to the level of the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

